A Study of SYH2051 Monotherapy in Advanced Solid Tumors or in Combination With Radiotherapy in Locally Advanced Head and Neck Cancer
Conditions: Solid Tumors; Head and Neck Cancer Interventions: Drug: SYH2051 tablets; Radiation: Intensity-Modulated Radiation Therapy (IMRT) Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Head and Neck Cancer | Intensity-Modulated Radiation Therapy | Radiation Therapy | Research | Study